| AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer (NCT00343408) | NCIC Clinical Trials Group | 2005-11-29 |
| Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer (NCT00905047) | Centre Oscar Lambret | 2005-11-14 |
| Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer (NCT00227747) | UNICANCER | 2005-11-08 |
| Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer (NCT00265850) | Alliance for Clinical Trials in Oncology | 2005-11-01 |
| Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases (NCT00265356) | Ontario Clinical Oncology Group (OCOG) | 2005-11-01 |
| A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. (NCT01227707) | Hoffmann-La Roche | 2005-11-01 |
| Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver (NCT00408551) | Goshen Health System | 2005-11-01 |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer (NCT00628368) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-11-01 |
| Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674) | Masonic Cancer Center, University of Minnesota | 2005-11-01 |
| PETACC-8 miR-31-3p and miR-31-5p Ancillary Study (NCT03362684) | IntegraGen SA | 2005-11-01 |
| Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery (NCT00265811) | Federation Francophone de Cancerologie Digestive | 2005-11-01 |
| Hepatic Artery Infusion With Oxaliplatin (NCT00244348) | Medical College of Wisconsin | 2005-10-01 |
| Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00559741) | Institut Cancerologie de l'Ouest | 2005-10-01 |
| Traditional Print Communication Methods, Simple Electronic Communication Methods, or Usual Care in Increasing How Often Older Women Undergo Colorectal Cancer Screening (NCT00459030) | Fox Chase Cancer Center | 2005-10-01 |
| Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women (NCT00136227) | Centers for Disease Control and Prevention | 2005-10-01 |
| Promoting Colorectal Cancer Screening in Rural Colorado (NCT00137592) | Centers for Disease Control and Prevention | 2005-10-01 |
| Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer (NCT00098787) | Eastern Cooperative Oncology Group | 2005-09-08 |
| Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00556413) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-09-01 |
| Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00128622) | H. Kim Lyerly | 2005-09-01 |
| Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea (NCT00197873) | University of Helsinki | 2005-09-01 |
| Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer (NCT00383695) | Royal Marsden NHS Foundation Trust | 2005-09-01 |
| Evaluating Tools for Health Promotion and Disease Prevention (NCT00164658) | Centers for Disease Control and Prevention | 2005-09-01 |
| Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC (NCT00313859) | Samsung Medical Center | 2005-09-01 |
| Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function (NCT00229567) | University of Saskatchewan | 2005-09-01 |
| Life After Cancer: Behavioral Treatment Study to Improve Quality of Life (NCT00473941) | Temple University | 2005-09-01 |
| Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer (NCT00276861) | University of Miami | 2005-09-01 |
| Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment (NCT00538291) | City of Hope Medical Center | 2005-08-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer (NCT00268333) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2005-08-01 |
| Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer (NCT00352638) | Fox Chase Cancer Center | 2005-08-01 |
| Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention (NCT00122187) | US Department of Veterans Affairs | 2005-08-01 |
| A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer (NCT02581423) | Hoffmann-La Roche | 2005-08-01 |
| Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer (NCT02877056) | M.D. Anderson Cancer Center | 2005-08-01 |
| Use of Novel Tailored Reminders in Rural Primary Care (NCT00593073) | University of Kansas | 2005-07-01 |
| Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer (NCT00238381) | Swiss Cancer Institute | 2005-07-01 |
| A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer (NCT00118755) | Hoffmann-La Roche | 2005-07-01 |
| Preoperative Assessment of Colon Tumor (NCT00114829) | Herlev Hospital | 2005-07-01 |
| Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) (NCT00125034) | Merck KGaA, Darmstadt, Germany | 2005-07-01 |
| Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment (NCT00154713) | National Taiwan University Hospital | 2005-07-01 |
| A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. (NCT00353262) | Hoffmann-La Roche | 2005-07-01 |
| Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer (NCT00165568) | Dana-Farber Cancer Institute | 2005-07-01 |
| Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer (NCT00499395) | UNC Lineberger Comprehensive Cancer Center | 2005-07-01 |
| Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment (NCT00449137) | University of Miami | 2005-06-01 |
| PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study (NCT00115765) | Amgen | 2005-06-01 |
| Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin (NCT00729677) | Beth Israel Medical Center | 2005-06-01 |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer (NCT00900835) | City of Hope Medical Center | 2005-06-01 |
| A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum (NCT01181609) | Hoffmann-La Roche | 2005-06-01 |
| A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum (NCT01131078) | Hoffmann-La Roche | 2005-06-01 |
| Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer (NCT00208546) | Dutch Colorectal Cancer Group | 2005-06-01 |
| EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide (NCT00132522) | EMD Serono | 2005-05-01 |
| Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer (NCT00120172) | Geriatric Oncology Consortium | 2005-05-01 |
| GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer (NCT00110721) | Galectin Therapeutics Inc. | 2005-05-01 |
| Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) (NCT00265824) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2005-05-01 |
| Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00217711) | Swiss Cancer Institute | 2005-05-01 |
| A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum (NCT02582970) | Hoffmann-La Roche | 2005-05-01 |
| Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery (NCT00466505) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer (NCT00114946) | Genentech, Inc. | 2005-05-01 |
| Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer (NCT00199797) | Ludwig Institute for Cancer Research | 2005-04-18 |
| An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin (NCT00165867) | Eisai Limited | 2005-04-01 |
| Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer (NCT00209742) | Hokkaido Gastrointestinal Cancer Study Group | 2005-04-01 |
| Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer (NCT00084721) | Roswell Park Cancer Institute | 2005-03-01 |
| Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00182715) | Velindre NHS Trust | 2005-03-01 |
| Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer (NCT00118261) | Case Comprehensive Cancer Center | 2005-03-01 |
| RCT of Automated Telephone Outreach to Improve Colorectal Cancer Screening (NCT00792285) | Harvard Pilgrim Health Care | 2005-03-01 |
| Computerized and Mailed Reminders in Increasing the Rate of Colorectal Cancer Screening in Adults With an Average Risk for Colorectal Cancer (NCT00355004) | Harvard Medical School (HMS and HSDM) | 2005-03-01 |
| Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer (NCT00559676) | Centre Hospital Regional Universitaire de Limoges | 2005-03-01 |
| Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer (NCT01032746) | Harvard University | 2005-03-01 |
| Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer (NCT00159432) | University of Southern California | 2005-02-01 |
| Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma (NCT00216424) | James A. Haley Veterans Administration Hospital | 2005-02-01 |
| Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer (NCT00103142) | Michael Morse, MD | 2005-02-01 |
| CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer (NCT00129870) | Sanofi | 2005-02-01 |
| The National CT Colonography Trial (NCT00084929) | American College of Radiology Imaging Network | 2005-02-01 |
| Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer (NCT00202787) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2005-02-01 |
| Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp (NCT00397969) | Harvard Medical School (HMS and HSDM) | 2005-02-01 |
| Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting (NCT01440855) | Fox Chase Cancer Center | 2005-02-01 |
| AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) (NCT00107250) | NCIC Clinical Trials Group | 2005-01-21 |
| Selenium for Prevention of Adenomatous Colorectal Polyps (NCT00078897) | University of Arizona | 2005-01-20 |
| Identification the Expression of Sox2 in Colorectal Cancer Tissues (NCT01589900) | Sun Yat-sen University | 2005-01-01 |
| Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer (NCT00209703) | Hokkaido Gastrointestinal Cancer Study Group | 2005-01-01 |
| Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay (NCT00696345) | Epigenomics, Inc | 2005-01-01 |
| Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles (NCT00868816) | Fudan University | 2005-01-01 |
| Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma (NCT00102024) | Biogen | 2005-01-01 |
| Shared Decision-Making for Colorectal Cancer Screening (NCT00251862) | Agency for Healthcare Research and Quality (AHRQ) | 2005-01-01 |
| Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients (NCT00354978) | M.D. Anderson Cancer Center | 2005-01-01 |
| Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer (NCT00116506) | Dana-Farber Cancer Institute | 2005-01-01 |
| MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) (NCT00099346) | Merck Sharp & Dohme LLC | 2005-01-01 |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer (NCT00559858) | Cambridge University Hospitals NHS Foundation Trust | 2004-12-01 |
| A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) (NCT00126451) | Merck Sharp & Dohme LLC | 2004-12-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer (NCT00112918) | Hoffmann-La Roche | 2004-12-01 |
| Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer (NCT00215982) | H. Lee Moffitt Cancer Center and Research Institute | 2004-12-01 |
| Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer (NCT00056030) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum (NCT00081224) | Alliance for Clinical Trials in Oncology | 2004-12-01 |
| Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer (NCT00103298) | National Cancer Institute (NCI) | 2004-12-01 |
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health (NCT00145015) | Quadram Institute Bioscience | 2004-12-01 |
| Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) (NCT00153998) | Technische Universität Dresden | 2004-11-01 |
| A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer (NCT00147134) | Haruhiko Fukuda | 2004-11-01 |
| Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients (NCT00582452) | Memorial Sloan Kettering Cancer Center | 2004-11-01 |
| Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer (NCT00427713) | Cancer Research UK | 2004-11-01 |
| Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (NCT00159484) | University of Southern California | 2004-10-12 |
| Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases (NCT00242086) | University Health Network, Toronto | 2004-10-01 |
| Randomized Trial of Colonic Stents as a Bridge to Surgery (NCT00758186) | Singapore General Hospital | 2004-10-01 |